In tests using animals, drug successfully seeks and disarms toxic clumps of proteins responsible for Alzheimer’s and Parkinson’s
An international team of more than 18 research groups has demonstrated that the compounds they developed can safely prevent harmful protein aggregation in preliminary tests using animals. The findings raise hope that a new class of drugs may be on the horizon for the more than 30 diseases and conditions that involve protein aggregation, including diabetes, cancer, spinal cord injury, Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS).
Proteins are necessary for almost every cellular process. However, when cell machinery doesn’t clear out old proteins, they can clump, or aggregate, into toxic plaques that lead to disease.
“Diseases caused by protein aggregation affect millions of people around the world,” said Gal Bitan, Ph.D., associate professor of neurology at the David Geffen School of Medicine at the University of California – Los Angeles, who will present the team’s latest work at the American Society for Biochemistry and Molecular Biology (ASBMB) Annual Meeting during Experimental Biology 2015. “We hope that the new compounds will provide therapy for diseases caused by protein aggregation, many of which have no treatment at all.”
The researchers call the compounds that they developed molecular tweezers because of the way they wrap around the lysine amino acid chains that make up most proteins. The compounds are unique in their ability to attack only aggregated proteins, leaving healthy proteins alone.
To develop a new drug, researchers typically screen large libraries of compounds to find ones that affect a protein involved in a disease. Bitan’s team used a fundamentally different approach to develop the molecular tweezers.
“We looked at the molecular and atomic interactions of proteins to understand what leads to their abnormal clumping,” Bitan said. “Then, we developed a tailored solution. So unlike many other drugs, we understand how and why our drug works.”
The team is in the process of testing multiple versions of the tweezers, each with a slightly different molecular makeup. For CLR01, one of the most promising versions, the researchers have demonstrated therapeutic benefits in two rodent models of Alzheimer’s disease, two fish and one mouse model of Parkinson’s disease, a fish model of spinal cord injury and a mouse model of familial amyloidotic polyneuropathy, a rare disease in which protein aggregation affects the nervous system, heart and kidneys.
“Our data suggest that CLR01, or a derivative thereof, may become a drug for a number of diseases that involve protein aggregation,” Bitan said. “We also found a high safety window for CLR01.”
In one of the safety tests, mice receiving a daily CLR01 dose 250 times higher than the therapeutic dose for one month showed no behavioral or physiological signs of distress or damage. In fact, blood cholesterol in the mice dropped by 40 percent, a possible positive side effect of CLR01.
The Latest on: Molecular tweezers
via Google News
The Latest on: Molecular tweezers
- Biochemical sensing in graphene-enhanced microfiber resonators with individual molecule sensitivity and selectivityon November 21, 2019 at 11:19 pm
The molecular interactions on prGO also induce spectral shifts between the longitudal ... The silica capillary (outer diameter 3 mm, inner diameter 125 μm, and length 10 mm) was held in the GO ...
- Light-based 'tractor beam' assembles materials at the nanoscaleon November 4, 2019 at 10:52 am
The optical tweezers act as a light-based 'tractor beam' that can assemble ... a UW associate professor of materials science and engineering, faculty member at the Molecular Engineering & Sciences ...
- Advanced particle manipulation with colloidal nanotweezerson September 16, 2019 at 1:17 am
Especially, manipulation of materials with light has led to significant breakthroughs in diverse field from atomic physics to microbiology and molecular medicine ... These devices are known as optical ...
- Tweezing cold moleculeson September 12, 2019 at 5:00 pm
Arrays of optical tweezers have been used to trap atoms, but trapping and laser-cooling molecules in this setting is tricky. Such an approach would, however, be generalizable to many molecular species ...
- Making perfectly controlled arrays of molecules at reston September 12, 2019 at 11:21 am
Individual molecules were brought together by tweezer traps, enabling their interaction. Such unprecedented control should allow high-precision observations of molecular collisions and could provide ...
- Focus: A Quantum Molecular Assembleron May 24, 2019 at 9:20 am
After crossing the two tweezer beams and turning off the sodium tweezer ... Assuming these tweaks work, a longer-lived molecular state would allow time for additional laser pulses to transfer the ...
- Using Laser Tweezers to Learn More About Protein Dropletson March 11, 2019 at 9:31 am
The researchers used optical tweezers, which are highly focused laser beams, to push protein droplets together in a solution. The droplets of proteins were found to easily merge, generating one larger ...
- Video: 'Optical Tweezers' App Lets Users Manipulate Microscopic Particles With an iPadon March 3, 2019 at 4:00 pm
Such a system should make the iPad a handy tool in molecular biology labs, where optical tweezers are an important tool. Moreover, while most people may have never operated optical tweezers, most have ...
- Laser tweezers used to boost liquid crystal technologyon February 23, 2019 at 5:06 pm
To create the defects in the liquid crystals, researchers with the Institute for Molecular Engineering at the University of Chicago and the University of Ljubljana used laser tweezers, a laser system ...
- Researchers use ‘laser tweezers’ to boost liquid crystal technologyon February 22, 2019 at 4:00 am
Liquid crystals, with their uniform molecular structure and orientation ... To create the defects in the liquid crystals, researchers used laser tweezers—a laser system that can manipulate particles ...
via Bing News